Navigation Links
Damon Runyon Cancer Research Foundation awards prestigious fellowships to 17 top young investigators
Date:12/12/2007

B>Michelle M. Boehm, PhD, with her sponsor Bonnie L. Bassler, PhD, at Princeton University, Princeton, New Jersey, is studying the basic mechanisms of cell-to-cell communication, a key process in the development of malignant cancer, using simple model organisms whose cellular communication has been well-defined.

  • Ken Cadwell, PhD, with his sponsor Herbert W. Virgin, IV, MD, PhD, at Washington University, St. Louis, Missouri, is using a novel mouse model to investigate autophagy, a cellular process that is intimately linked to cancer and human disease.

  • Erhu Cao, PhD, with his sponsor David J. Julius, PhD, at the University of California, San Francisco, California, is investigating the structure and function of sensory transient receptor potential (TRP) channels for better management of cancer-related pain.

  • Alexandra M. Deaconescu, PhD, with her sponsor Nikolaus Grigorieff, PhD, at Brandeis University, Waltham, Massachusetts, is investigating how adenomatous polyposis coli, the most commonly mutated protein in colorectal cancers, nucleates actin and regulates the organization of the cellular cytoskeleton.

  • Erik W. Debler, PhD, with his sponsor Gnter Blobel, MD, PhD, at The Rockefeller University, New York, New York, is investigating core structures of the nuclear pore complex (NPC). Chromosomal translocations of NPC proteins are linked to various types of cancer, including myeloid and lymphoid leukemias.

  • Gianna Elena Hammer, PhD, with her sponsor Averil Ma, MD, at the University of California, San Francisco, California, is investigating how dendritic cells, the regulators of T cell function, detect infection or cancer and then coordinate protective immune responses.

  • Yoh Isogai, PhD, with his sponsor Catherine Dulac, PhD, at Harvard University, Cambridge, Massachusetts, is investigating causes and effects of stress hormone ACTH perturbation, a hall
    '/>"/>

  • Contact: Clare M. Cahill
    clare.cahill@drcrf.org
    212-455-0520
    Damon Runyon Cancer Research Foundation
    Source:Eurekalert

    Page: 1 2 3 4

    Related biology news :

    1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
    2. A study by the MUHC and McGill University opens a new door to understanding cancer
    3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
    4. Protein chatter linked to cancer activation
    5. Newly created cancer stem cells could aid breast cancer research
    6. Western diet linked to increased risk of colon cancer recurrence
    7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
    8. Low levels of key protein may indicate pancreatic cancer risk
    9. Birth records hold pancreatic cancer clue
    10. Many parents at-risk for cancer disclose genetic test results to children
    11. A new radiation therapy treatment developed for head and neck cancer patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/21/2014)... team has successfully replicated one of the crucial steps ... by sunlight which could manufacture hydrogen as a fuel. ... is an exciting prospect to use them to create ... Kastoori Hingorani, from the ARC Centre of Excellence for ... , Hydrogen offers potential as a zero-carbon replacement for ...
    (Date:8/20/2014)... Cancer Institute (HCI) at the University of Utah have ... encodes BCR-ABL, the unregulated enzyme driving the blood cancer ... Society, nearly 6,000 new cases of CML will be ... tyrosine kinase inhibitors (TKIs), target BCR-ABL and are effective ... but control it in a way that allows patients ...
    (Date:8/20/2014)... population-based screening outcomes of approximately 3 million infants, a ... at the University of Massachusetts Medical School, have shown ... be successfully implemented across public health newborn screening programs. ... Aug. 20 issue of the Journal of the ... rate of SCID in newborns is higher than previously ...
    Breaking Biology News(10 mins):Water and sunlight the formula for sustainable fuel 2Blueprint for next generation of chronic myeloid leukemia treatment 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3
    ... the Faculty of Veterinary Medicine at Universitat Autnoma ... Research in Agricultural Genomics (CRAG), the Centre for ... for Agrarian Technology and Research in Madrid and ... the first partial genome sequencing of an Iberian ...
    ... The debate surrounding carbon capture and storage intensifies as ... Berkeley National Laboratory (Berkeley Lab) examine the capacity for ... in the new journal Greenhouse Gases: Science & ... the conclusions drawn in an earlier study by Ehlig-Economides ...
    ... biochemistry is how proteins recognize "correct" interaction partners in ... critical to know than in the brain, where interactions ... A team of biologists at the Salk Institute for ... regulates availability of a brain channel that modulates neuronal ...
    Cached Biology News:First partial sequencing of an Iberian pig 2Carbon capture and storage: Carbon dioxide pressure dissipates in underground reservoirs 2Salk scientists crack molecular code regulating neuronal excitability 2Salk scientists crack molecular code regulating neuronal excitability 3
    (Date:8/21/2014)... Sofia, Bulgaria (PRWEB) August 21, 2014 ... was released today by Ontotext . Now ... and semantic analysis of structured and unstructured data is ... of the cost of enterprise technology. Organizations that do ... approaches for data management can use S4 since there ...
    (Date:8/20/2014)... 2014 Clintrax Global, Inc., a worldwide ... Raleigh, NC , recently announced the ... President of Administration. As Vice ... processes, including their alignment with company objectives and ... as an HR executive, specializing in needs assessments, ...
    (Date:8/20/2014)... Neurotrope, Inc. (OTCQB: NTRP) today announced ... provide an update on Company activities. Access information:Date:Tuesday, ... 505-4369 (U.S. and Canada) or (719) 325-2315 Conference ... under "Investor Relations"The teleconference replay will be available ... 2014 at (888) 203-1112 (U.S. and ...
    (Date:8/20/2014)... Francisco, CA (PRWEB) August 20, 2014 ... Conference is being held on October 29-30 in ... perspectives from industry, academic and government researchers and clinicians ... in the space. , In the twelve years ... one hundred therapies have been introduced with pharmacogenetic information ...
    Breaking Biology Technology:Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4Clintrax Global, Inc. Announces Addition to Executive Team 2Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2
    ... Shionogi-ViiV Healthcare, LLC announced today that the first ... designed to support a new fixed-dose combination (FDC) ... investigational regimen, known as 572-Trii, will combine the ... combination nucleoside reverse transcriptase inhibitor (NRTI) Kivexa®/Epzicom® (ABC/3TC). ...
    ... TRIANGLE PARK, N.C., Feb. 2, 2011 The day ... off the shelf for use in life-saving vascular surgeries ... published in the current issue of the journal, ... vascular grafts (TEVGs) that are immediately-available at the time ...
    ... Inc. (Nasdaq: SGMO ) today reported fourth quarter ... For the fourth quarter ended December 31, 2010, Sangamo ... per share, compared to a net loss of $2.4  million, ... As of December 31, 2010, the company had cash, cash ...
    Cached Biology Technology:Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 2Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 3Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 4Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 5Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 6Shionogi-ViiV Healthcare Starts Phase III Trial for '572-Trii' Fixed-Dose Combination HIV Therapy 7Bioengineered veins offer new hope on horizon for patients lacking healthy veins for coronary bypass surgery or dialysis 2Bioengineered veins offer new hope on horizon for patients lacking healthy veins for coronary bypass surgery or dialysis 3Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 2Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 3Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 4Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 5Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 6Sangamo BioSciences Reports Fourth Quarter and Full Year 2010 Financial Results 7
    ...
    The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
    ... work area that will help protect your ... irradiate the work area prior to use, ... be amplified. Containment features reduce the chance ... acrylic windows for a clear view, an ...
    ... Have you bought a Perkin Elmer UltraVIEW system ... the Andor iXon and iQ software? No problem. ... upgrade. You keep your existing microscope, lasers, Sutter ... customise it to work with our precision controller ...
    Biology Products: